Trial Watch: Peptide vaccines in cancer therapy

Mostrar otras versiones (1)

Throughout the past 3 decades, along with the recognition that the immune system not only influences oncogenesis and tumor progression, but also determines how established neoplastic lesions respond therapy, renovated enthusiasm has gathered around the possibility of using vaccines as anticancer age...

Descripción completa

Detalles Bibliográficos
Autores principales: Aranda, Fernando, Vacchelli, Erika, Eggermont, Alexander, Galon, Jerome, Sautès-Fridman, Catherine, Tartour, Eric, Zitvogel, Laurence, Kroemer, Guido, Galluzzi, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902120/
https://www.ncbi.nlm.nih.gov/pubmed/24498550
http://dx.doi.org/10.4161/onci.26621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902120/
https://www.ncbi.nlm.nih.gov/pubmed/24498550
http://dx.doi.org/10.4161/onci.26621

Ejemplares similares